Cargando…
Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases
The discovery of the Estrogen Receptor Beta (ERβ) in 1996 opened new perspectives in the diagnostics and therapy of different types of cancer. Here, we present a review of the present research knowledge about its role in endocrine-related cancers: breast, prostate, and thyroid, and colorectal cancer...
Autores principales: | Božović, Ana, Mandušić, Vesna, Todorović, Lidija, Krajnović, Milena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914503/ https://www.ncbi.nlm.nih.gov/pubmed/33562134 http://dx.doi.org/10.3390/ijms22041656 |
Ejemplares similares
-
Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications
por: Krajnović, Milena, et al.
Publicado: (2023) -
VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma
por: Todorović, Lidija, et al.
Publicado: (2023) -
Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000) -
The role of estrogen receptor beta in breast cancer
por: Zhou, Yujing, et al.
Publicado: (2020) -
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
por: Austin, David, et al.
Publicado: (2018)